Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Corey

Showing results (161-170 of 222) with videos related to

Pageof 23
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2025
Targeting AXL Inhibits the Growth and Metastasis of Prostate Cancer in BoneChun-Lung Chiu, Dalin Zhang, Hongjuan Zhao, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Increased chromatin accessibility mediated by nuclear factor I drives transition to androgen receptor splice variant dependence in castration-resistant prostate cancerLarysa Poluben, Mannan Nouri, Jiaqian Liang, et al.
Cancer Research|July 27, 2021
RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate CancerMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Nature Genetics|September 2, 2020
Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancerShuai Gao, Sujun Chen, Dong Han, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|November 13, 2023
Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancerAnna Testa, Fabio Quaglia, Nicole M Naranjo, et al.
Nature Communications|August 5, 2024
Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancerPengfei Xu, Joy C Yang, Bo Chen, et al.
Cell Reports|December 22, 2024
Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancerLarysa Poluben, Mannan Nouri, Jiaqian Liang, et al.
Cancer Research Communications|October 12, 2023
Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate CancersAilin Zhang, Nathan A Lau, Alicia Wong, et al.
JCI Insight|May 23, 2022
Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistromeXintao Qiu, Lisha G Brown, Jennifer L Conner, et al.
The Prostate|June 19, 2019
Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancerLaura H Porter, Mitchell G Lawrence, Hong Wang, et al.
Pageof 23

Showing results (161-170 of 222) with videos related to

Sort By:
Pageof 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2025
Targeting AXL Inhibits the Growth and Metastasis of Prostate Cancer in BoneChun-Lung Chiu, Dalin Zhang, Hongjuan Zhao, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Increased chromatin accessibility mediated by nuclear factor I drives transition to androgen receptor splice variant dependence in castration-resistant prostate cancerLarysa Poluben, Mannan Nouri, Jiaqian Liang, et al.
Cancer Research|July 27, 2021
RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate CancerMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Nature Genetics|September 2, 2020
Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancerShuai Gao, Sujun Chen, Dong Han, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|November 13, 2023
Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancerAnna Testa, Fabio Quaglia, Nicole M Naranjo, et al.
Nature Communications|August 5, 2024
Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancerPengfei Xu, Joy C Yang, Bo Chen, et al.
Cell Reports|December 22, 2024
Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancerLarysa Poluben, Mannan Nouri, Jiaqian Liang, et al.
Cancer Research Communications|October 12, 2023
Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate CancersAilin Zhang, Nathan A Lau, Alicia Wong, et al.
JCI Insight|May 23, 2022
Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistromeXintao Qiu, Lisha G Brown, Jennifer L Conner, et al.
The Prostate|June 19, 2019
Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancerLaura H Porter, Mitchell G Lawrence, Hong Wang, et al.
Pageof 23